Range
- - -
Vol / Avg.
-/850K
Div / Yield
-
52 Wk
2.4 - 24.25
Mkt Cap
735.1M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.17
Shares
32.5M
Outstanding
32.5M
Total Float
30M
load more
Sector: Health Care.Industry: Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-01-13
REV
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-23
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Oramed Pharmaceuticals Questions & Anwsers

Q

How do I buy Oramed Pharmaceuticals (ORMP) stock?

A

You can purchase shares of Oramed Pharmaceuticals (NASDAQ: ORMP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oramed Pharmaceuticals's (ORMP) competitors?

Q

What is the target price for Oramed Pharmaceuticals (ORMP) stock?

A

The latest price target for Oramed Pharmaceuticals (NASDAQ: ORMP) was reported by Canaccord Genuity on July 29, 2021. The analyst firm set a price target for 30.00 expecting ORMP to rise to within 12 months (a possible 32.68% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Oramed Pharmaceuticals (ORMP)?

A

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $22.61 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

A

There are no upcoming dividends for Oramed Pharmaceuticals.

Q

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

A

Oramed Pharmaceuticals’s $Q1 earnings are confirmed for after-market on $January 13, 2022.

Q

Is Oramed Pharmaceuticals (ORMP) going to split?

A

There is no upcoming split for Oramed Pharmaceuticals.

Q

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

A

Oramed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.